Attitudes towards Social Networking and Sharing Behaviors among Consumers of Direct-to-Consumer Personal Genomics
Author(s): Sandra Soo-Jin Lee | Simone L. Vernez | K.E. Ormond | Mark Granovetter
Volume: 3
Issue: 4
Year: 2013
Author(s): Sandra Soo-Jin Lee | Simone L. Vernez | K.E. Ormond | Mark Granovetter Volume: 3 Issue: 4 Year: 2013
Understanding the Economic Value of Molecular Diagnostic Tests: Case Studies and Lessons Learned
Author(s): Adrian Towse | Diego Ossa | David Veenstra | Josh Carlson | Louis Garrison
Volume: 3
Issue: 4
Year: 2013
Author(s): Adrian Towse | Diego Ossa | David Veenstra | Josh Carlson | Louis Garrison Volume: 3 Issue: 4 Year: 2013
Open Access Integrated Therapeutic and Diagnostic Platforms for Personalized Cardiovascular Medicine
Author(s): Patrick A. Gladding | Andrew Cave | Mehran Zareian | Kevin Smith | Jagir Hussan | Peter Hunter | Folarin Erogbogbo | Zoraida Aguilar | David S. Martin | Eugene Chan | Margie L. Homer | Abhijit V. Shevade | Mohammad Kassemi | James D. Thomas | Todd T. Schlegel
Volume: 3
Issue: 3
Year: 2013
Author(s): Patrick A. Gladding | Andrew Cave | Mehran Zareian | Kevin Smith | Jagir Hussan | Peter Hunter | Folarin Erogbogbo | Zoraida Aguilar | David S. Martin | Eugene Chan | Margie L. Homer | Abhijit V. Shevade | Mohammad Kassemi | James D. Thomas | Todd T. Schlegel Volume: 3 Issue: 3 Year: 2013
Examining the Relationship between Choice, Therapeutic Alliance and Outcomes in Mental Health Services
Author(s): Victoria Stanhope | Stacey L. Barrenger | Mark S. Salzer | Stephen C. Marcus
Volume: 3
Issue: 3
Year: 2013
Author(s): Victoria Stanhope | Stacey L. Barrenger | Mark S. Salzer | Stephen C. Marcus Volume: 3 Issue: 3 Year: 2013
A Method for Biomarker Directed Survival Prediction in Advanced Non-Small-Cell Lung Cancer Patients Treated with Carboplatin-Based Therapy
Author(s): Wei Chen | Gerold Bepler
Volume: 3
Issue: 3
Year: 2013
Author(s): Wei Chen | Gerold Bepler Volume: 3 Issue: 3 Year: 2013
Antisense Therapy in Neurology
Author(s): Joshua J. A. Lee | Toshifumi Yokota
Volume: 3
Issue: 3
Year: 2013
Author(s): Joshua J. A. Lee | Toshifumi Yokota Volume: 3 Issue: 3 Year: 2013
“Just Caring”: Can We Afford the Ethical and Economic Costs of Circumventing Cancer Drug Resistance?
Author(s): Leonard M. Fleck
Volume: 3
Issue: 3
Year: 2013
Author(s): Leonard M. Fleck Volume: 3 Issue: 3 Year: 2013
Effect Model Law: An Approach for the Implementation of Personalized Medicine
Author(s): Jean-Pierre Boissel | Riad Kahoul | Draltan Marin | François-Henri Boissel
Volume: 3
Issue: 3
Year: 2013
Author(s): Jean-Pierre Boissel | Riad Kahoul | Draltan Marin | François-Henri Boissel Volume: 3 Issue: 3 Year: 2013
Personalized Cancer Care Conference
Author(s): Kurt S. Zänker | Enrico Mihich | Hans-Peter Huber | Anne-Lise Borresen-Dale
Volume: 3
Issue: 2
Year: 2013
Author(s): Kurt S. Zänker | Enrico Mihich | Hans-Peter Huber | Anne-Lise Borresen-Dale Volume: 3 Issue: 2 Year: 2013
Motivations and Barriers to Sharing Biological Samples: A Case Study
Author(s): Stacey Pereira
Volume: 3
Issue: 2
Year: 2013
Author(s): Stacey Pereira Volume: 3 Issue: 2 Year: 2013
Machine Learning Techniques for Arterial Pressure Waveform Analysis
Author(s): Vânia G. Almeida | João Vieira | Pedro Santos | Tânia Pereira | H. Catarina Pereira | Carlos Correia | Mariano Pego | João Cardoso
Volume: 3
Issue: 2
Year: 2013
Author(s): Vânia G. Almeida | João Vieira | Pedro Santos | Tânia Pereira | H. Catarina Pereira | Carlos Correia | Mariano Pego | João Cardoso Volume: 3 Issue: 2 Year: 2013
Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information
Author(s): Eric J. Stanek | Christopher L. Sanders | Felix W. Frueh
Volume: 3
Issue: 2
Year: 2013
Author(s): Eric J. Stanek | Christopher L. Sanders | Felix W. Frueh Volume: 3 Issue: 2 Year: 2013
Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization
Author(s): Frank S. Ong | Jane Z. Kuo | Wei-Chi Wu | Ching-Yu Cheng | Wendell-Lamar B. Blackwell | Brian L. Taylor | Wayne W. Grody | Jerome I. Rotter | Chi-Chun Lai | Tien Y. Wong
Volume: 3
Issue: 1
Year: 2013
Author(s): Frank S. Ong | Jane Z. Kuo | Wei-Chi Wu | Ching-Yu Cheng | Wendell-Lamar B. Blackwell | Brian L. Taylor | Wayne W. Grody | Jerome I. Rotter | Chi-Chun Lai | Tien Y. Wong Volume: 3 Issue: 1 Year: 2013
Driving Forces Behind the Past and Future Emergence of Personalized Medicine
Author(s): Julius Alexander Steffen | Jan Simon Steffen
Volume: 3
Issue: 1
Year: 2013
Author(s): Julius Alexander Steffen | Jan Simon Steffen Volume: 3 Issue: 1 Year: 2013
Structured Decision-Making: Using Personalized Medicine to Improve the Value of Cancer Care
Author(s): Bradford R. Hirsch | Amy P. Abernethy
Volume: 3
Issue: 1
Year: 2012
Author(s): Bradford R. Hirsch | Amy P. Abernethy Volume: 3 Issue: 1 Year: 2012
Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
Author(s): Irina Piatkov | Trudi Jones | Mark McLean
Volume: 2
Issue: 4
Year: 2012
Author(s): Irina Piatkov | Trudi Jones | Mark McLean Volume: 2 Issue: 4 Year: 2012
An Altered Treatment Plan Based on Direct to Consumer (DTC) Genetic Testing: Personalized Medicine from the Patient/Pin-cushion Perspective
Author(s): Jessica D. Tenenbaum | Andra James | Kristin Paulyson-Nuñez
Volume: 2
Issue: 4
Year: 2012
Author(s): Jessica D. Tenenbaum | Andra James | Kristin Paulyson-Nuñez Volume: 2 Issue: 4 Year: 2012
Developing a Prototype System for Integrating Pharmacogenomics Findings into Clinical Practice
Author(s): Casey Lynnette Overby | Peter Tarczy-Hornoch | Ira J. Kalet | Kenneth E. Thummel | Joe W. Smith | Guilherme Del Fiol | David Fenstermacher | Emily Beth Devine
Volume: 2
Issue: 4
Year: 2012
Author(s): Casey Lynnette Overby | Peter Tarczy-Hornoch | Ira J. Kalet | Kenneth E. Thummel | Joe W. Smith | Guilherme Del Fiol | David Fenstermacher | Emily Beth Devine Volume: 2 Issue: 4 Year: 2012
Insurance Coverage Policies for Personalized Medicine
Author(s): Andrew Hresko | Susanne B. Haga
Volume: 2
Issue: 4
Year: 2012
Author(s): Andrew Hresko | Susanne B. Haga Volume: 2 Issue: 4 Year: 2012
Pattern of Timing Adherence Could Guide Recommendations for Personalized Intake Schedules
Author(s): Philipp Walter | Isabelle Arnet | Michel Romanens | Dimitrios A. Tsakiris | Kurt E. Hersberger
Volume: 2
Issue: 4
Year: 2012
Author(s): Philipp Walter | Isabelle Arnet | Michel Romanens | Dimitrios A. Tsakiris | Kurt E. Hersberger Volume: 2 Issue: 4 Year: 2012
The Making of a CYP3A Biomarker Panel for Guiding Drug Therapy
Author(s): Danxin Wang | Wolfgang Sadee
Volume: 2
Issue: 4
Year: 2012
Author(s): Danxin Wang | Wolfgang Sadee Volume: 2 Issue: 4 Year: 2012
Personalized Health Care as a Pathway for the Adoption of Genomic Medicine
Author(s): Robin Burnette | Leigh Ann Simmons | Ralph Snyderman
Volume: 2
Issue: 4
Year: 2012
Author(s): Robin Burnette | Leigh Ann Simmons | Ralph Snyderman Volume: 2 Issue: 4 Year: 2012
A Database-driven Decision Support System: Customized Mortality Prediction
Author(s): Leo Anthony Celi | Sean Galvin | Guido Davidzon | Joon Lee | Daniel Scott | Roger Mark
Volume: 2
Issue: 4
Year: 2012
Author(s): Leo Anthony Celi | Sean Galvin | Guido Davidzon | Joon Lee | Daniel Scott | Roger Mark Volume: 2 Issue: 4 Year: 2012
Individual Oral Therapy with Immediate Release and Effervescent Formulations Delivered by the Solid Dosage Pen
Author(s): Klaus Wening | Eva Julia Laukamp | Markus Thommes | Jörg Breitkreutz
Volume: 2
Issue: 4
Year: 2012
Author(s): Klaus Wening | Eva Julia Laukamp | Markus Thommes | Jörg Breitkreutz Volume: 2 Issue: 4 Year: 2012
Teenagers as a Moving Target: How Can Teenagers Be Encouraged to Accept Treatment?
Author(s): Pascale Gauthier | Jean-Michel Cardot
Volume: 2
Issue: 4
Year: 2012
Author(s): Pascale Gauthier | Jean-Michel Cardot Volume: 2 Issue: 4 Year: 2012
Aligning the Economic Value of Companion Diagnostics and Stratified Medicines
Author(s): Edward D. Blair | Elyse K. Stratton | Martina Kaufmann
Volume: 2
Issue: 4
Year: 2012
Author(s): Edward D. Blair | Elyse K. Stratton | Martina Kaufmann Volume: 2 Issue: 4 Year: 2012
Statin Pharmacogenomics: Opportunities to Improve Patient Outcomes and Healthcare Costs with Genetic Testing
Author(s): William J. Canestaro | David G. Brooks | Donald Chaplin | Niteesh K. Choudhry | Elizabeth Lawler | Lori Martell | Troyen Brennan | E. Robert Wassman
Volume: 2
Issue: 4
Year: 2012
Author(s): William J. Canestaro | David G. Brooks | Donald Chaplin | Niteesh K. Choudhry | Elizabeth Lawler | Lori Martell | Troyen Brennan | E. Robert Wassman Volume: 2 Issue: 4 Year: 2012
Challenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare System
Author(s): David E. Dawe | Peter M. Ellis
Volume: 2
Issue: 3
Year: 2012
Author(s): David E. Dawe | Peter M. Ellis Volume: 2 Issue: 3 Year: 2012
Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report
Author(s): Steven R. Schuster | Barbara A. Pockaj | Mary R. Bothe | Paru S. David | Donald W. Northfelt
Volume: 2
Issue: 3
Year: 2012
Author(s): Steven R. Schuster | Barbara A. Pockaj | Mary R. Bothe | Paru S. David | Donald W. Northfelt Volume: 2 Issue: 3 Year: 2012
Health 2050: The Realization of Personalized Medicine through Crowdsourcing, the Quantified Self, and the Participatory Biocitizen
Author(s): Melanie Swan
Volume: 2
Issue: 3
Year: 2012
Author(s): Melanie Swan Volume: 2 Issue: 3 Year: 2012
Field of Genes: An Investigation of Sports-Related Genetic Testing
Author(s): Jennifer K. Wagner | Charmaine D. Royal
Volume: 2
Issue: 3
Year: 2012
Author(s): Jennifer K. Wagner | Charmaine D. Royal Volume: 2 Issue: 3 Year: 2012
Molecular Therapeutic Advances in Personalized Therapy of Melanoma and Non-Small Cell Lung Cancer
Author(s): Fergal C. Kelleher | Benjamin Solomon | Grant A. McArthur
Volume: 2
Issue: 2
Year: 2012
Author(s): Fergal C. Kelleher | Benjamin Solomon | Grant A. McArthur Volume: 2 Issue: 2 Year: 2012
Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic Technologies
Author(s): Luc Bissonnette | Michel G. Bergeron
Volume: 2
Issue: 2
Year: 2012
Author(s): Luc Bissonnette | Michel G. Bergeron Volume: 2 Issue: 2 Year: 2012
Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective
Author(s): Roman Fleck | Daniel Bach
Volume: 2
Issue: 1
Year: 2012
Author(s): Roman Fleck | Daniel Bach Volume: 2 Issue: 1 Year: 2012
Developing Drugs for Children and the Adjustment of Medication—Is It a New Challenge or an Adaptation of Past Ideas?
Author(s): Pascale Gauthier | Jean-Michel Cardot
Volume: 1
Issue: 1
Year: 2011
Author(s): Pascale Gauthier | Jean-Michel Cardot Volume: 1 Issue: 1 Year: 2011
Welcome to the Journal of Personalized Medicine: A New Open-Access Platform for Research on Optimal Individual Healthcare
Author(s): Urs A. Meyer
Volume: 1
Issue: 1
Year: 2011
Author(s): Urs A. Meyer Volume: 1 Issue: 1 Year: 2011
